{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:59:21Z","timestamp":1787007561723,"version":"build-2736575974"},"reference-count":101,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T00:00:00Z","timestamp":1697500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Gastroenterology & Hepatology"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1080\/17474124.2023.2268503","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T10:11:21Z","timestamp":1697537481000},"page":"1135-1147","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments"],"prefix":"10.1080","volume":"17","author":[{"given":"B\u00e9atrice","family":"Laup\u00e8ze","sequence":"first","affiliation":[{"name":"GSK Vaccines, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ventzislav","family":"Vassilev","sequence":"additional","affiliation":[{"name":"GSK Vaccines, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Badur","sequence":"additional","affiliation":[{"name":"GSK Vaccines, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.056"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26475-6"},{"key":"e_1_3_7_5_1","unstructured":"World Health Organization. Hepatitis B vaccination coverage. [cited 2022 Oct 4]. Available from: https:\/\/immunizationdata.who.int\/pages\/coverage\/hepb.html?CODE=Global&ANTIGEN=&YEAR="},{"key":"e_1_3_7_6_1","unstructured":"World Health Organization. Hepatitis B. Fact Sheet. [cited 2022 Oct 2]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.11.011"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2028483"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051114"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.65"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.1.68-76.2003"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00549-4"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13614"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301073"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i30.3347"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12090998"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13081463"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/v9060156"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.009"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.024"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i27.3527"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.42"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1942673"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.648420"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix356"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi4670"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.05.041"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i30.10395"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000360947"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.02.001"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14040657"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.06.006"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32314"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733364"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba6322"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i48.6145"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156200"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-409"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13150"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.091"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104815"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14020434"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10099-x"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.023"},{"key":"e_1_3_7_47_1","volume-title":"Proceedings from The Liver Meeting","author":"Gane E","year":"2022","unstructured":"Gane E, Janczewska E, Takehara T, et al. Efficacy and safety of siRNA JNJ-73763989, capsid assembly modulator JNJ-56136379, nucleos(t)ide analog, and pegylated interferon alpha-2a for the treatment of chronic hepatitis b: week 24 results from the phase 2 PENGUIN study. Proceedings from The Liver Meeting; 2022 Nov 04-08. Washington: AASLD. Available from https:\/\/natap.org\/2022\/AASLD\/AASLD_57.htm"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(23)03307-X"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.03.005"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/v14092052"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01513-4"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2210027"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156667"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-0267-2_5"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-020-00534-w"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0618-8278(19)30084-2"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(20)30766-2"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(93)90003-6"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250631"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.07.014"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118592"},{"issue":"3","key":"e_1_3_7_62_1","first-page":"162","article-title":"Using immunomodulatory and antiviral strategies in the quest to cure hepatitis B virus infection","volume":"18","author":"Gehring AJ","year":"2022","unstructured":"Gehring AJ. Using immunomodulatory and antiviral strategies in the quest to cure hepatitis B virus infection. Gastroenterol Hepatol (NY). 2022;18(3):162\u2013165.","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-014-0379-5"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.028"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)00538-4"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13085"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.016"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.03.044"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112754"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)02030-X"},{"key":"e_1_3_7_71_1","unstructured":"Press release. Arbutus doses first patient in additional treatment arm of phase 2a triple combination clinical trial that includes a PD-1 monoclonal antibody. 2023 Jun 21 [cited 2023 Sep 10]. Available from: https:\/\/investor.arbutusbio.com\/news-releases\/news-release-details\/arbutus-doses-first-patient-additional-treatment-arm-phase-2a"},{"key":"e_1_3_7_72_1","unstructured":"Brii Biosciences announces topline interim results of phase 2 study evaluating BRII-179 (VBI-2601) in combination with PEG-IFN\u03b1 for the treatment of chronic hepatitis B. 2023 Sep 06 [cited 2023 Sep 9]. Available from https:\/\/www.briibio.com\/en\/media\/press-release\/20230906\/."},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6010006"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100361"},{"key":"e_1_3_7_75_1","article-title":"GS-2829\/GS-6779 HBV therapeutic vaccine generates robust, polyfunctional, genotype cross-reactive CD8 T cell responses accompanied by high titers of anti-HBsAg antibodies","volume":"76","author":"Schmidt S","year":"2022","unstructured":"Schmidt S, Daffis S, Ahmadi-Erber S, et al. GS-2829\/GS-6779 HBV therapeutic vaccine generates robust, polyfunctional, genotype cross-reactive CD8 T cell responses accompanied by high titers of anti-HBsAg antibodies. Hepatology. 2022;76:S22\u2012S23.","journal-title":"Hepatology"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)00541-4"},{"key":"e_1_3_7_77_1","volume-title":"Viral Hepatitis Elimination (VHE) congress","author":"Swinnen K","year":"2022","unstructured":"Swinnen K, Romero Gomez M, Sprinzl K, et al. Targeted immunotherapy with heterologous prime-boost and adjuvanted hepatitis B core (HBc)\/surface (HBs) proteins in adult chronic hepatitis B patients showed positive HBc- and HBs-specific CD8+ and CD4+ T cell responses in a phase I\/II trial. PO-207. Viral Hepatitis Elimination (VHE) congress, Feb 24\u201325. 2022."},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(23)03313-5"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13851"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.003"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.037"},{"issue":"2","key":"e_1_3_7_82_1","first-page":"S757","article-title":"Safety and efficacy of oral TLR8 agonist, selgantolimod, in viremic adult patients with chronic hepatitis B","volume":"75","author":"Janssen HLA","year":"2021","unstructured":"Janssen HLA, Lim YS, Kim HJ, et al. Safety and efficacy of oral TLR8 agonist, selgantolimod, in viremic adult patients with chronic hepatitis B. J Hepatol. 2021;75(Suppl 2):S757\u2013S758.","journal-title":"J Hepatol"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169631"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00771-17"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101205"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(22)01959-6"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i21.2344"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.003"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.10.001"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104748"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072076"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4275"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00776-0"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1952851"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(23)00488-9"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(23)00618-9"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00849"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103464"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075916"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17052"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.08.023"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/v9050096"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-022-00816-x"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00398-x"}],"container-title":["Expert Review of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474124.2023.2268503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T14:36:12Z","timestamp":1727188572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474124.2023.2268503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":101,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1080\/17474124.2023.2268503"],"URL":"https:\/\/doi.org\/10.1080\/17474124.2023.2268503","relation":{},"ISSN":["1747-4124","1747-4132"],"issn-type":[{"value":"1747-4124","type":"print"},{"value":"1747-4132","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierh20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierh20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}